granulocyte colony-stimulating factor (filgrastim) in patients with advanced breast cancer
暂无分享，去创建一个
M. Nicolson | T. Powles | M. O'Brien | S. Ashley | A. Montes | A. Tidy | M. O'Brien | M. Nicolson | A. Montes | S. Ashley
[1] M. Baum,et al. Primary medical (neo-adjuvant) chemotherapy for operable breast cancer. , 1993, European journal of cancer.
[2] R. M. Fox,et al. Effect of peripheral-blood progenitor cells mobilised by filgrastim (G-CSF) on platelet recovery after high-dose chemotherapy , 1992, The Lancet.
[3] A. Howell,et al. The use of granulocyte colony-stimulating factor to increase the intensity of treatment with doxorubicin in patients with advanced breast and ovarian cancer. , 1989, British Journal of Cancer.
[4] R. Rubens,et al. Assessment of response to therapy in advanced breast cancer. , 1977, British Journal of Cancer.